Medifast
MED
162 hedge funds and large institutions have $438M invested in Medifast in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 61 reducing their positions, and 16 closing their positions.
12% more capital invested
Capital invested by funds: $390M → $438M (+$48.2M)
0.64% more ownership
Funds ownership: 88.13% → 88.77% (+0.64%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 16
7% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 61
2% less funds holding
Funds holding: 165 → 162 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$7.46M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.31M |
| 3 |
Bank of New York Mellon
New York
|
+$2.34M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.67M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$5.8M |
| 2 |
Two Sigma Investments
New York
|
-$3.04M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.95M |
| 4 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
-$2.56M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.59M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
176
Tower Research Capital (TRC)
New York
| – | +$40 | +1 | +100% |
|
177
AssetMark Inc
Concord,
California
| – | +$121 | +3 | New |
|
178
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$362 | +9 | New |
|
MED Hedge Fund Activity: Q4 2016 in Review
162 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2016, worth a combined $438M — up 12% from $390M a quarter earlier.
Fund positioning in MED was balanced in Q4 2016: 16 funds opened new positions, 16 closed out, 57 added to existing stakes and 61 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $7.46M. The largest seller was Arrowstreet Capital, exiting entirely with an estimated $5.8M sold.
- 162 institutional investors held Medifast (MED) as of Q4 2016, down from 165 in Q3 2016.
- Funds reported $438M of Medifast stock for Q4 2016, up 12% quarter-over-quarter.
- 16 funds opened new Medifast positions in Q4 2016 and 16 closed out, a net change of 0 holders.
- The largest Medifast buyer in Q4 2016 was Acadian Asset Management, an estimated $7.46M added.
- The largest Medifast seller in Q4 2016 was Arrowstreet Capital, an estimated $5.8M sold.
Based on aggregated 13F filings for Q4 2016.